课题基金 / 基金详情

IRFs Regulate Cell Cycle and Growth Inhibitory Genes in

IRFs Regulate Cell Cycle and Growth Inhibitory Genes in
IRF 调节细胞周期和生长抑制基因
批准号:
6675559
负责人:
Charles E Egwuagu
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Charles E Egwuagu的其他基金

相似基金

相关文献

中文摘要
翻译
干扰素调节因子(IRF)家族的两个成员,IRF-1和ICSBP(干扰素一致序列结合蛋白)是肿瘤抑制因子,对造血细胞具有有效的生长抑制作用。我们之前的研究表明,IRF-1和ICSBP在小鼠晶状体中有差异表达,其水平或空间分布在发育中的晶状体中的扰动会抑制晶状体的生长。在这项研究中,我们研究了它们在晶状体细胞中抑制生长作用的分子机制。将小鼠IRF-1或ICSBP编码序列克隆到哺乳动物表达载体中,转染a- tn1 -1晶状体上皮细胞系。采用RNase保护实验、Western blotting、免疫沉淀、体外增殖实验和凝胶移位实验检测IRF-1或ICSBP对晶状体细胞生长、细胞周期、肿瘤抑制基因、凋亡基因和生长抑制基因的转录的影响。我们发现IRF-1和ICSBP都能抑制晶状体细胞的生长,其生长抑制作用是通过上调细胞周期调节蛋白(p130、周期蛋白依赖性激酶抑制剂p21和p27)、凋亡蛋白(caspase 1)和肿瘤抑制因子p53介导的。虽然这两种irf表现出重叠的功能,但它们对晶状体细胞也有不同的影响;IRF-1和ICSBP诱导p21, ICSBP也增强p27和IRF-1的表达。两种蛋白均不影响Rb、Bcl-2/w/x、Bak、Bax或Bad基因的表达。我们进一步表明,凋亡和生长调节蛋白的诱导是通过IRF-1/ICSBP与这些基因启动子中IFN应答元件的相互作用介导的。我们首次提供了由IRF-1和ICSBP介导的JAK/STAT信号通路调节对晶状体生长和分化至关重要的蛋白质的经验证据。因此,我们的数据表明,这一涉及造血细胞生长和分化的重要转录因子家族也可能通过其对晶状体细胞周期和生长因子/细胞因子信号传导的影响,在控制晶状体生长和分化中发挥作用。
英文摘要
Two members of the Interferon regulatory factor (IRF) family, IRF-1 and ICSBP (Interferon consensus sequence binding protein) are tumor suppressors and have potent growth inhibitory effects on hematopoietic cells. We previously showed that that IRF-1 and ICSBP are differentially expressed in the mouse lens and that perturbation of their levels or spatial distribution in the developing lens inhibited lens growth. In this study, we investigated the molecular mechanisms underlying their growth inhibitory effects in lens cells. Coding sequence of murine IRF-1 or ICSBP was cloned into a mammalian expression vector and used to transfect the a-TN4-1 lens epithelial cell line. Stable transfectants were established by selection in hygromycin B. The effects of IRF-1 or ICSBP on lens cell growth, transcription of cell cycle, tumor suppressor, apoptosis, and growth inhibitory genes were examined by RNase protection assay, Western blotting, immunoprecipitation, in vitro proliferation assay and gel-shift assay. We show that both IRF-1 and ICSBP inhibite the growth of the lens cells and that the growth inhibitory effects are mediated by up-regulation of cell cycle regulatory proteins (p130, cyclin-dependent kinase inhibitors p21 & p27), apoptotic-proteins (caspase 1) and the tumor suppressor p53. Although the two IRFs exhibit overlapping functions, they also have distinct effects on the lens cells; whereas IRF-1 and ICSBP induce p21, ICSBP also enhance p27 and IRF-1 expression. Neither protein affected Rb, Bcl-2/w/x, Bak, Bax or Bad gene expression. We further show that induction of the apoptotic and growth regulatory proteins is mediated by IRF-1/ICSBP interactions with IFN responsive elements in promoters of these genes. We provide for the first time empirical evidence that JAK/STAT signaling pathways mediated by IRF-1 and ICSBP regulate proteins that are critical to lens growth and differentiation. Our data therefore suggest that this important family of transcription factors implicated in hematopoietic cell growth and differentiation may also play a role in controling lens growth and differentiation through their effects on the cell cycle and growth factors/cytokine signaling in the lens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interferon-inducible Transcription Factors: Roles In Ocu
  • 批准号:
    6507394
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Charles E Egwuagu
  • 依托单位:
INTERFERON INDUCIBLE TRANSCRIPTION FACTORS: ROLES IN OCU
  • 批准号:
    6414669
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Charles E Egwuagu
  • 依托单位:
Role of IL-12 family cytokines in human autoimmune Uveit
  • 批准号:
    7321809
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Charles E Egwuagu
  • 依托单位:
Development of dendritic cell vaccine against uveitis
  • 批准号:
    6968529
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Charles E Egwuagu
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: